Journal of Carcinogenesis & Mutagenesis
Overview
Journal of Carcinogenesis & Mutagenesis is a scientific journal, published by Omics Publishing Group since 2010 in English. The journal's country of origin is United States.
Details
Details
Abbr.
J Carcinog Mutagen
Publisher
Omics Publishing Group
Start
2010
End
Continuing
Frequency
Bimonthly
e-ISSN
2157-2518
Country
United States
Language
English
Recent Articles
1.
Diakite M, Diakite B, Kone A, Balam S, Fofana D, Diallo D, et al.
J Carcinog Mutagen
. 2023 May;
13(3).
PMID: 37206892
Excessive consumption of red and processed meat has been associated with a higher risk of developing colorectal cancer. There are many attempts to explain the risk of colorectal cancer associated...
2.
Etekpo A, Alghawalby A, Alghawalby M, Soliman A, Hablas A, Chen B, et al.
J Carcinog Mutagen
. 2021 Jun;
9(1).
PMID: 34164227
Pancreatic cancer is the fourth cause of cancer deaths in the U.S. with most patients diagnosed at advanced stages followed by short survival. Therefore, biomarkers for early detection are urgently...
3.
Karri N, Xie H, Wise Sr J
J Carcinog Mutagen
. 2020 Dec;
4(2).
PMID: 33312751
Hexavalent chromium [Cr(VI)] compounds are well established human lung carcinogens, but it is unknown how they cause lung cancer in humans. Recent data indicate that Cr(VI) induces chromosome instability in...
4.
Peluso M, Munnia A, Tarocchi M, Arciello M, Balsano C, Giese R, et al.
J Carcinog Mutagen
. 2019 Sep;
2013(Suppl 3).
PMID: 31528500
Introduction: Non-alcoholic fatty liver disease is the most common hepatic disorder in Western countries. The transition from abnormal accumulation of lipids toward non-alcoholic steatohepatitis (NASH) represents a key step in...
5.
Wallace L, Cherian A, Adamson P, Bari S, Banerjee S, Flood M, et al.
J Carcinog Mutagen
. 2018 Nov;
9(2).
PMID: 30393577
Objective: Colorectal cancer (CRC) develops from precancerous adenomatous polyps to malignant lesions of adenocarcinoma. Elucidating inhibition mechanisms for this route in patients with a risk of developing CRC is highly...
6.
Chandrakesan P, Panneerselvam J, Qu D, Weygant N, May R, Bronze M, et al.
J Carcinog Mutagen
. 2016 Jun;
7(2).
PMID: 27335684
The identification of functionally relevant subpopulations of therapy-resistant cancer cells is a challenge. These cells, intrinsically resistant to conventional therapy, can cause recurrence. Evidence has suggested that therapy-resistant cancer cells...
7.
Diette N, Koo J, Cabarcas-Petroski S, Schramm L
J Carcinog Mutagen
. 2016 May;
7(1).
PMID: 27158556
Background: RNA polymerase (pol) III transcribes a variety of untranslated RNAs responsible for regulating cellular growth and is deregulated in a variety of cancers. In this study, we examined gender...
8.
Carpenter R, Lo H
J Carcinog Mutagen
. 2016 Apr;
2013(Suppl 7).
PMID: 27088047
HER2 is a trans-membrane receptor tyrosine kinase that activates multiple growth-promoting signaling pathways including PI3K-AKT and Ras-MAPK. Dysregulation of HER2 is a frequent occurrence in breast cancer that is associated...
9.
Rettino A, Clarke N
J Carcinog Mutagen
. 2015 Apr;
(Spec Iss Apoptosis).
PMID: 25893139
IRF1 is a transcription factor involved in interferon signaling and has been shown to harbor tumor suppressor activity. In order to comprehensively identify pathways regulated by IRF1, we used chromatin...
10.
Bernard J, Lou Y, Peng Q, Li T, Vakil P, Ding N, et al.
J Carcinog Mutagen
. 2015 Mar;
5(183):2157-2518.
PMID: 25821644
Objective: In the present study, we sought to investigate how a HFD may influence the intrinsic properties of the parametrial fat tissue to influence UVB-induced skin tumor formation. Methods And...